Sign in
Taking peopleNo phase

Tranexamic Acid in Pediatric Idiopathic Scoliosis Surgery

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
90 people, planned
Started
6 May 2026
Expected to end
30 Jun 2027
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Tranexamic Acid Bolus Plus Infusion
  • Sodium Chloride 0.9% Inj
  • Tranexamic Acid Bolus Only
Record updated
5 November 2026

Who can take part

Age
10 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Age 10 to 18 years
  • Diagnosis of idiopathic scoliosis requiring surgical correction (posterior spinal fusion)
  • American Society of Anesthesiologists (ASA) physical status I-II
  • Written informed consent from parents or legal guardians and assent from the child

Who cannot take part

  • History of thromboembolic disease
  • History of seizures or epilepsy
  • Known hypersensitivity to tranexamic acid
  • Renal insufficiency (estimated glomerular filtration rate < 60 mL/min/1.73 m²)
  • Cardiac arrhythmias or cardiovascular disease requiring antiplatelet or anticoagulant therapy
  • Congenital or acquired coagulopathy

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 10 and 18 years old?

This trial is currently available in Poland.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will evaluate whether tranexamic acid (TXA), a medication used to reduce bleeding, is effective and safe in children undergoing surgery for idiopathic scoliosis. Significant blood loss is common during this type of surgery and often requires blood transfusions.

Read full original descriptionShow less

Participants will be randomly assigned to one of three groups: (1) TXA given as an intravenous bolus followed by continuous infusion, (2) TXA given as two intravenous bolus doses, or (3) placebo (saline). Neither the patients nor the medical team will know which treatment is given.

The main goal is to compare how much blood is lost during and after surgery and whether TXA reduces the need for blood transfusions. The study will also assess safety, including the risk of side effects such as seizures or blood clots.

Patients will be followed for up to 30 days after surgery.

The 3 groups in the trial

  • TXA Bolus + InfusionTreatment being tested

    Tranexamic acid administered intravenously as a 15 mg/kg bolus after induction of anesthesia, followed by continuous infusion at 1 mg/kg/h until the end of surgery. Maximum total dose not exceeding 2 g. All patients receive standardized anesthesia (TIVA with propofol and remifentanil), erector spinae plane block, and intraoperative neuromonitoring.

    Treatment: Tranexamic Acid Bolus Plus Infusion

  • PlaceboPlacebo, for comparison

    0.9% sodium chloride (saline) administered intravenously in the same volumes and timing as the active comparator groups (bolus and infusion). All patients receive standardized anesthesia (TIVA with propofol and remifentanil), erector spinae plane block, and intraoperative neuromonitoring.

    Treatment: Sodium Chloride 0.9% Inj

  • TXA Bolus OnlyTreatment being tested

    Tranexamic acid administered intravenously as two bolus doses: 10 mg/kg after induction of anesthesia and 10 mg/kg 120 minutes after surgical incision or at the beginning of rod placement (whichever occurs first). Maximum total dose not exceeding 2 g. All patients receive standardized anesthesia (TIVA with propofol and remifentanil), erector spinae plane block, and intraoperative neuromonitoring.

    Treatment: Tranexamic Acid Bolus Only

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy and Safety of Two Intravenous Tranexamic Acid Regimens Versus Placebo in Pediatric Idiopathic Scoliosis Surgery: A Randomized Double-Blind Trial
Criteria questions
Built from NCT07581457, who can take part
Record updated
5 November 2026